Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014

Although clinical trials of first- and second-generation tyrosine kinase inhibitors (TKIs) have been shown to improve the prognosis of chronic myeloid leukemia (CML), there is still uncertainty about the clinical features, treatment outcomes, adverse effects, and other possible problems of their use...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Exp Hematop
Hauptverfasser: Kawano, Noriaki, Yoshida, Shuro, Kawano, Sayaka, Kuriyama, Takuro, Yamashita, Kiyoshi, Ochiai, Hidenobu, Shimoda, Kazuya, Ishikawa, Fumihiko, Ueda, Akira, Kikuchi, Ikuo
Format: Artigo
Sprache:Inglês
Veröffentlicht: JSLRT 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144279/
https://ncbi.nlm.nih.gov/pubmed/27334856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.34
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge